Navegando por Palavras-chave "Isoflavones"
Agora exibindo 1 - 20 de 20
Resultados por página
Opções de Ordenação
- ItemAcesso aberto (Open Access)Análise do estresse oxidativo e da apoptose no ovário de ratas tratadas com isoflavonas da soja(Universidade Federal de São Paulo (UNIFESP), 2018-05-24) Teixeira, Cristiane de Paula [UNIFESP]; Simões, Manuel de Jesus [UNIFESP]; http://lattes.cnpq.br/5987164343458678; http://lattes.cnpq.br/0572410240696130; Universidade Federal de São Paulo (UNIFESP)O envelhecimento ovariano caracteriza se pela diminuição da reserva folicular e diminuição da qualidade dos oócitos que culminou na menopausa, responsável por uma série de distúrbios e doenças crônicas que afetam seriamente a qualidade de vida das mulheres. O estresse oxidativo parece modular o declínio da fertilidade relacionado com a idade, induzindo a senescência celular e a apoptose. Os antioxidantes são investigados por atrasar o envelhecimento, e as isoflavonas de soja podem atuar como antioxidantes e inibir a apoptose. Objetivos: Analisar a apoptose e a modulação do estresse oxidativo no ovário de ratas de 3 e 12 meses de idade tratadas com isoflavonas da soja. Métodos: Vinte e seis ratas Wistar de 3 e 12 meses foram divididas em quatro grupos e diariamente tratadas com extrato de isoflavonas da soja (150 mg/kg/dia) ou apenas com solução veículo propilenoglicol por gavagem. Após oito semanas, os animais foram eutanasiados e os ovários retirados. O ovário direito foi processado para estudo morfológico (% de folículos ovarianos em seus diferentes estágios) e avaliado a apoptose (caspase 3 e BCL2). No ovário esquerdo foram analisados os níveis de espécies reativas de oxigênio, a capacidade antioxidante total e os níveis de peroxidação dos lipídeos, como biomarcador do estresse oxidativo. Resultados: Na análise histomorfométrica, notou se uma diminuição significativa apenas na percentagem de folículos atrésicos nas ratas de 12 meses que receberam isoflavonas. Observou se ainda uma diminuição significativa no número de células caspase 3 positivas nos animais de 3 e 12 meses submetidos às isoflavonas, já a imunopositividade para BCL2 apresentou se significativamente aumentada somente nas ratas de 12 meses. O tratamento com isoflavonas ainda promoveu aumento significativo da capacidade antioxidante total, além da diminuição significativa dos níveis de espécies reativas de oxigênio e da peroxidação dos lipídeos nas ratas de 3 e 12 meses. Conclusão: As isoflavonas da soja parecem reduzir a atresia folicular, a apoptose e o estresse oxidativo, bem como aumentam a capacidade antioxidante total no ovário de ratas. E, em parte, os efeitos anti apoptóticos das isoflavonas parecem estar relacionados com sua capacidade antioxidante.
- ItemAcesso aberto (Open Access)Avaliação da Memória Prospectiva antes e após o uso do extrato concentrado de soja, em mulheres na pós-menopausa com queixa de alteração de memória(Universidade Federal de São Paulo (UNIFESP), 2013) Laprano Vieira, Lucia Helena [UNIFESP]; Silva, Ivaldo [UNIFESP]; Haidar, Mauro Abi [UNIFESP]; Dardes, Rita de Cassia de Maio [UNIFESP]; http://lattes.cnpq.br/3864318683297398; http://lattes.cnpq.br/3773357188654076; http://lattes.cnpq.br/9948402316193744; http://lattes.cnpq.br/4605481134945295O objetivo deste estudo foi analisar os efeitos do extrato concentrado de soja na memoria prospectiva (MP), apos a menopausa, por meio de avaliacao neuropsicologica. Correlacionou-se o desempenho no teste de MP, com testes de funcoes cognitivas. (funcoes atencionais, executivas, memoria, viso-motora, abstracao e linguagem), escalas de autopercepcao e depressao. Realizou-se estudo randomizado, duplo-cego, prospectivo, com 84 pacientes na posmenopausa, atendidas no Setor de Transicao Menopausal e Pos-Menopausa da Disciplina de Endocrinologia Ginecologia, do Departamento de Ginecologia da Universidade Federal de São Paulo u Escola Paulista de Medicina (UNIFESPEPM). As pacientes foram divididas, conforme programa de randomizacao, em dois grupos Grupo I - receberam 150mg de extrato concentrado de soja sob a forma de uma capsula com 60mg de isoflavonas totais, por via oral/dia; Grupo II - receberam uma capsula contendo substancia inativa (placebo), durante seis meses. Os nossos resultados demonstraram que as mulheres em uso de extrato de isoflavonas tiveram melhora clinicamente (autopercepcao) no desempenho da memoria prospectiva (MP), entretanto nao foi possivel estabelecer correlacao destes resultados com o desempenho cognitivo. O extrato concentrado de soja teve um efeito favoravel sobre a funcao cognitiva, dentre todas as funcoes, somente na memoria verbal e tarefas da funcao executiva de planejamento e flexibilidade mental, nas demais nao teve melhora. Concluimos que o extrato concentrado tem acao somente em algumas funcoes cognitivas
- ItemAcesso aberto (Open Access)Avaliação do colágeno no osso de ratas diabéticas tipo 1 tratadas com isoflavonas(Universidade Federal de São Paulo, 2022-11-29) Vieira, Magno César [UNIFESP]; Simões, Manuel de Jesus [UNIFESP]; Carbone, Adriana Aparecida Ferraz [UNIFESP]; http://lattes.cnpq.br/9174521191304809; http://lattes.cnpq.br/5987164343458678; http://lattes.cnpq.br/5998705224419140Neste trabalho, o modelo “ratas diabéticas ovariectomizadas” foi utilizado pensando nas mulheres em menopausa e diabéticas com um tratamento alternativo com isoflavonas da soja, baseamo-nos em dados que mostram um aumento no número de mulheres que procuram utilizar-se de terapias hormonais. Objetivo: Analisar a matriz extracelular no osso de ratas diabéticas tratadas com isoflavonas ou 17β- estradiol. Métodos: Foram utilizadas 60 ratas (Rattus norvegicus albinus), fêmeas, adultas, ±3 meses de idade. Os animais foram separados em seis (6) grupos, a saber: controle Sham (n=10) animais não ovariectomizados na fase de estro; Sham+DM (n=10) controle Sham ratas diabéticas não ovariectomizadas na fase de estro; OVX (n=10) controle, ratas ovariectomizadas que receberam veículo propilenoglicol; OVX+DM (n=10) ratas diabéticas ovariectomizadas que receberam veículo propilenoglicol (fase de estro); OVX+DM+ISO (n=10) animais diabéticos ovariectomizados tratados com isoflavonas da soja (150mg/Kg, por gavagem); OVX+DM+E2 (n=10) animais diabéticos ovariectomizados tratados com estrogênio (17β-estradiol, 10μg/Kg, por via subcutânea). Para a indução do diabetes Tipo 1, as ratas receberam uma única injeção intraperitoneal de 60 mg/Kg de estreptozotocina (STZ, Sigma-Aldrich). O diabetes foi confirmado três dias após a injeção da estreptozotocina. Todos os animais foram tratados durante 30 dias consecutivos, e ao final, os animais foram anestesiados e os fêmures removidos e processados para estudo em H.E. e Picro Sirius Red. Para a análise dos resultados foi utilizado Oneway ANOVA seguido do teste de Tukey. Foram considerados estatisticamente significativos experimentos cujo valor de p foi menor que 5% (p ≤ 0,05) para significância estatística. Os cálculos foram feitos com o programa SPSS versão13 (SPSS, Chicago, IL). Resultados: Os resultados obtidos foram os seguintes: Peso corporal: não foi diferente entre os grupos não diabéticos Sham e OVX e, os grupos de ratas diabéticas Sham+DM, OVX+DM, OVX+DM+ISO e OVX+DM+E2 (p>0,05). No entanto, houve uma diminuição significativa do peso corporal nos grupos de ratas diabéticas em comparação com os grupos não diabéticas Sham e OVX (p<0,001). Sensibilidade à Insulina: Os valores mais baixos de insulina tolerância foram observadas no OVX+DM (2,41±0,95). Os grupos Sham (4,64±0,95) e OVX (4,57±0,58) apresentaram os maiores valores de sensibilidade à insulina (p<0,001). x Os grupos OVX+DM+ISO e OVX+DM+E2 apresentaram valores semelhantes, inferiores aos Sham e OVX e superior ao grupo OVX+DM. Histomorfometria e Análise Bioquímica de Glicosaminoglicanos Sulfatados: O volume do osso trabecular foi maior nos grupos de ratas diabéticas ovariectomizadas OVX+DM+E2 (26,35±2,13) e OVX+DM+ISO (18,36±173), tratadas, respectivamente, com 17β estradiol e isoflavonas e menor no OVX+DM (8,32±2,52), grupo de ratas diabéticas ovariectomizadas que receberam veículo propilenoglicol em fase de estro. Resultados semelhantes foram encontrados em relação à espessura do osso cortical, que foi maior no OVX+DM+E2 (398,4±1,74) e OVX+DM+ISO (295,6±1,45) e menor no OVX+DM (142,6±2,74) (p<0,05). Com relação ao sulfato de condroitina foi encontrado nos ossos de todos os grupos de animais estudados. Picro Sirius Red: As fibras colágenas de substância óssea trabecular e cortical das epífises dos fêmures apresentaram maior intensidade de birrefringência nos grupos (OVX+DM+ISO 330,2±2 e OVX+DM+E2 414,8± 33,7) tratados, respectivamente, com isoflavonas e 17β estradiol
- ItemAcesso aberto (Open Access)Does soy increase blood counts in myelodysplastic syndromes?(Sociedade Brasileira de Patologia ClínicaSociedade Brasileira de PatologiaSociedade Brasileira de Citopatologia, 2010-10-01) Viana, T. A. O. F. [UNIFESP]; Claricia, E. [UNIFESP]; Pinheiro, R. F. [UNIFESP]; Panizzi, M. C. C.; Sandes, Alex Freire [UNIFESP]; Carvalho, V. M.; Sesso, Ricardo de Castro Cintra [UNIFESP]; Yamamoto, Mihoko [UNIFESP]; Atallah, Álvaro Nagib [UNIFESP]; Chauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Empresa Brasileira de Pesquisa Agropecuária Centro Nacional de Pesquisa de Soja; Instituto FleuryMyelodysplastic syndromes (MDS) are a group of clonal stem cell diseases characterized by ineffective hematopoiesis, bone marrow hyperproliferation, cytopenias in peripheral blood and risk of transformation into acute leukemia. We decided to investigate the effects of a soy concentrate on MDS patients based on the follow-up results of a 61 year-old Japanese female patient who was diagnosed with MDS and refractory cytopenia with multilineage dysplasia in 2003 (hemoglobin = 11g/dL; white blood cells count = 2,500/uL and platelets = 25,000/uL; marrow with mild dysplasia and normal karyotype; paroxysmal nocturnal hemoglobinuria was excluded). She started using soy as a dietary supplementation in May 2004 and presented a gradual increment in blood counts, achieving normalization approximately eight months afterwards. Among the soy components, the main compounds with anti-carcinogenic activity are the isoflavones (genistein and daidzein). Based on these lines of evidence, we proposed to administer daily a standard soy concentrate to 14 MDS out-patients for a minimum period of three months and maximum of 12 months, in an attempt to evaluate prospectively the possible increase in hemoglobin, neutrophils and platelet counts. A historical control group was used to compare results. The use of a soy concentrate in a standardized manner was associated with an increase in neutrophil and/or platelet counts in some cases, but spontaneous increments were also observed in historical controls. This preliminary study does not allow establishing a relation between soy supplementation and blood cell count increase.
- ItemAcesso aberto (Open Access)Efeito das Isoflavonas da Soja na expressão gênica e histomorfometria na glândula adrenal de ratas ovariectomizadas(Universidade Federal de São Paulo (UNIFESP), 2016-05-31) Marinho, Darci Souza [UNIFESP]; Bertoncini, Clélia Rejane Antônio [UNIFESP]; http://lattes.cnpq.br/6913838606609313; http://lattes.cnpq.br/4459748931781505; Universidade Federal de São Paulo (UNIFESP)In the last decades the life expectancy has increased due to socio-economic development and the improvement of medical care provided to population. In this sense most women will experience a post-menopausal stage of life exposing themselves to deleterious effects of estrogen deprivation. This led to the development of hormone replacement therapy, which is mainly used for relief of vasomotor and urogenital symptoms, as well as to reduce osteoporosis and cardiovascular disease risk. In consequence of some contraindications of this method, many studies aim the development of alternative therapies hat can benefit women's health. Among them we can highlight the use of phytoestrogens such as isoflavones, a vegetal no-steroidal compound that induces biological responses by modulating the actions of endogenous estrogens by binding to its receptors. In this study we analyzed the histomorphometry and the gene expression of Ki-67, VEGF and caspase 3 in the adrenal gland of ovariectomized rats treated with estrogen or isoflavones. We used 15 Wistar rats ovariectomized treated with isoflavones estrogen for 30 days. Treatment with estrogen showed a largest increase in the layers of the adrenal than isoflavones. These hypertrofic effects agree with the gene expression elevation of Ki67 and VEGF, which did not occur with the caspase 3, indicating that isoflavones have great proliferative effect on the adrenal gland but no protective effect against apoptosis. Taken together, our results indicate positively the therapeutic potential of isoflavones and can contribute to the development of effective therapies to decrease the symptoms of menopause.
- ItemAcesso aberto (Open Access)Efeito terapêutico das isoflavonas no metabolismo e na função renal em animais submetidos à dieta hiperlipídica rica em frutose(Universidade Federal de São Paulo (UNIFESP), 2017-07-31) Pessoa, Edson de Andrade [UNIFESP]; Borges, Fernanda Teixeira [UNIFESP]; http://lattes.cnpq.br/4206613998602417; http://lattes.cnpq.br/1831498061607525; Universidade Federal de São Paulo (UNIFESP)A obesidade é considerada uma epidemia mundial e um fator de risco para inúmeras patologias como diabetes, hipertensão e doença renal. A dieta hiperlipídica, rica em carboidratos, como a frutose, mimetiza muitas das alterações associadas a obesidade. O objetivo deste trabalho foi avaliar o efeito da dieta hiperlipídica rica em frutose sobre o metabolismo e função renal em ratos e elucidar o possível efeito terapêutico das isoflavonas nestas condições. Ratos Wistar foram divididos em: animais controle (CTL), submetidos a dieta controle por 120 dias (17,70% lipídios, 61,74% carboidratos e 20,56% proteína), animais submetidos a dieta hiperlipídica (DH) rica em frutose (68,27% lipídios, 16,41% de frutose e 15,32% proteína) durante 120 dias e grupo de animais submetidos a DH por 120 e nos últimos 60 dias tratados com isoflavonas (300 mg/kg, por gavage). A DH induziu aumento de consumo de calorias, no peso e acúmulo de gordura visceral. Causou aumento na glicemia, hemoglobina glicada, uricemia e promoveu resistência à insulina. Houve elevação no colesterol total, triglicérides, diminuição no HDL-C. Na função renal observamos aumento na creatinina e ureia plasmáticas, fração de excreção de sódio, proteinúria e diminuição no clearance de creatinina, associados ao aumento na marcação para KIM-1 tubular. Houve aumento na pressão arterial sistêmica, enquanto na hemodinâmica renal observamos diminuição no fluxo sanguíneo renal e aumento na resistência vascular renal. A DH induziu uma inflamação renal subclínica com aumento no TNFα, IL1-β e IL-6 e infiltração de macrófagos. Estes efeitos foram mediados pelo estresse oxidativo (aumento na peroxidação lipídica) e nitrosilativo (aumento no NO) renal. As isoflavonas reverteu praticamente todas estas alterações sem interferir no consumo de calorias, principalmente via efeitos antioxidantes e anti-inflamatórios. As isoflavonas pode ser uma opção terapêutica no tratamento ou prevenção das alterações metabólicas e renais associadas a obesidade.
- ItemSomente MetadadadosEfeitos da isoflavona e o estrogênio na qualidade de vida na pós-menopausa(Universidade Federal de São Paulo (UNIFESP), 2005) Laprano Vieira, Lucia Helena [UNIFESP]; Haidar, Mauro Abi [UNIFESP]0 objetivo deste estudo é analisar os efeitos da isoflavona e do estrogênio na qualidade de vida, de mulheres na pós-menopausa, durante seis meses, utilizando-se de questionário específico construído para a menopausa (MENQOL ou Menopause-Specific Quality of Life) e critério de classificação sócio econômica. Realizou-se estudo randomizado, duplo-cego, prospectivo, com 79 pacientes na pós-menopausa, atendidas no Setor de Climatério, da Disciplina de Endocrinologia Ginecologia, do Departamento de Ginecologia da Universidade Federal de São Paulo - Escola Paulista de Medicina (UNIFESP-EPM), no período de seis meses. As pacientes foram divididas, conforme programa de randomização, em dois grupos: o grupo I recebeu estrogênio, por via oral (uma cápsula de 0,625mg de estrogênios conjugados eqüinos e, outra, era de placebo) e o grupo II recebeu isoflavona, por via oral (uma cápsula com 60 mg de isoflavonas cada, duas vezes ao dia).
- ItemAcesso aberto (Open Access)Efeitos das isoflavonas em altas doses sobre o útero da rata(Associação Médica Brasileira, 2011-10-01) Carbonel, Adriana Aparecida Ferraz [UNIFESP]; Simões, Ricardo Santos; Santos, Regiane Helena Barros Rabelo [UNIFESP]; Baracat, Maria Cândida Pinheiro; Simões, Manuel de Jesus [UNIFESP]; Baracat, Edmund Chada [UNIFESP]; Soares Júnior, José Maria [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade de São Paulo (USP)OBJECTIVE: To evaluate the effects of high-dose isoflavones on the uterus of castrated adult rats. METHODS: Adult, ovariectomized virgin rats (n = 40) were treated by gavage during 30 consecutive days with vehicle (propylene glycol, group GCtrl) or different doses of genistein: 42 (group GES42), 125 (GES125), or 250 (GES250) µg/g body weight per day. Animals were killed, weighed, vaginal and uterine samples were taken for cytologic evaluation, and serum levels of 17 β-estradiol and progesterone were determined. The middle third of the uterine horns was dissected, fixed in 10% formaldehyde and processed for paraffin inclusion; 5-µm thick sections were obtained and stained with HE for further histological study under light microscopy. The endometrial morphology and area, number and area of glands, and number of eosinophils in the lamina propria were analyzed. ANOVA and the Tukey-Kramer test were used for statistical analyses. RESULTS: Uterine weight, endometrial glandular area, and number of glands and eosinophils were all higher in GES250 > G125 than in the other groups (GES250 > GES125 > GES42 = GCtrl; p < 0.05). Morphological data showed signs of endometrial proliferation upon treatment with genistein, especially in animals in GES125 and GES250 compared to other groups. In all animals in GES250, signs of uterine squamous metaplasia were observed. CONCLUSION: A short treatment period with high daily doses of isoflavones can promote endometrial squamous metaplasia in ovariectomized rats.
- ItemAcesso aberto (Open Access)Efeitos das isoflavonas sobre o miométrio de ratas adultas(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2006-04-01) Mosquette, Rejane [UNIFESP]; Gomes, Milena Pires de Campos Luciano [UNIFESP]; Simões, Ricardo Santos [UNIFESP]; Haidar, Mauro Abi [UNIFESP]; Simões, Manuel de Jesus [UNIFESP]; Soares Júnior, José Maria [UNIFESP]; Baracat, Edmund Chada [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade de São Paulo (USP)PURPOSE: to evaluate histomorphometric changes in the rat myometrium upon treatment with isoflavones, as compared with estrogens, using histological and morphometric techniques. METHODS: twenty-eight oophorectomized adult rats were randomly divided into four treatment groups: GPropi = propylene glycol (control); GExtr10 - 10 mg/kg soybean extract; GExtr300 - 300 mg/kg soy bean extract; GCee - 200 µg/kg conjugated equine estrogens (Cee). Drugs or drug vehicle were administered by gavage once a day for 21 days. Upon sacrifice, the uteri were removed and weighed. Fragments of uterine horns were collected and fixed in 10% formaldehyde and processed for paraffin inclusion. The histological sections were stained by hematoxylin and eosin and evaluated microscopically by means of an image analyzer to quantify the myometrial thickness and the number of blood vessels and eosinophils. The data were studied by analysis of variance (ANOVA) followed by the Tukey-Kramer multiple comparison test. RESULTS: isoflavones in the concentration of 300 mg/kg induced a significant increase in the myometrium thickness (GExtr300=25.6±5.0 mm) compared to control (GPropi=5.5±0.5 mm). The effect of this high dose is similar to the estrogen effect (GCee=27.5±7.9 mm). In low doses (10 mg/kg), the effect was similar to control. Isoflavones (GExtr300) induced also an increase in the number of blood vessels (GPropi=3.5±1.6; GExtr300=10.2±3.6 vessels/mm²) and of eosinophils (CPropi=0.15±0.01; GExtr300=4.3±0.9 eosinophils/mm²). These effects were comparable to those produced by Cee treatment in GCee (9.2±1.1 eosinophils/mm²). CONCLUSION: a high-dose treatment with isoflavones (300 mg/kg per day, 21 days) elicited an estrogen-like, highly significant proliferative action on the rat myometrium.
- ItemAcesso aberto (Open Access)Efeitos de altas doses de genisteína sobre o epitélio mamário de ratas(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2011-09-01) Carbonel, Adriana Aparecida Ferraz [UNIFESP]; Santos, Regiane Helena Barros Rabelo [UNIFESP]; Simões, Ricardo Santos; Florencio-Silva, Rinaldo [UNIFESP]; Soares Júnior, José Maria [UNIFESP]; Baracat, Edmund Chada [UNIFESP]; Haidar, Mauro Abi [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade de São Paulo (USP)PURPOSE: to evaluate the effects of high doses of genistein on the mammary glands of adult female rats. METHODS: Twenty-eight days after oophorectomy, 50 adult female rats were divided into five groups, as follows: a control group (Ctrl), three rats that received genistein (GEN) at the doses of 46 mg/kg (GEN46;), 125 mg/kg (GEN125) and 250 mg/kg (GEN250); one group received conjugated equine estrogen at the dose of 50 µg/g (ECE50). The substances were administered daily for 30 consecutive days by gavage and in the last week of the period of treatment, colpocytological exams were carried out for seven consecutive days. After treatment, the animals were anesthetized, blood samples were collected for estradiol and progesterone determination and the first pair of inguinal mammary glands was removed and processed for histomorphometric analysis. Collected data were subjected to analysis of variance supplemented by the Tukey-Kramer test (p<0.05). RESULTS: the ctrl group and the ones treated with different doses of GEN showed atrophic mammary glands, whereas the glands were more developed in the ECE group, where numerous mammary ducts and alveoli were observed. Morphometry showed a larger area of mammary parenchyma in the ECE group (98.870.1±550.4 µm²* per mm²; p<0.05) compared with other groups (Ctrl=36.875.6±443.4; GEN46=37.001.7±557.4; GEN125=36.480.8±658.3 and GEN250=37.502.8±669.3). The same occurred in the number of alveoli in the ECE group (33.2±6.9* per mm²; p<0.05) compared to the other groups (Ctrl=10.4±2.1, GEN46=11.2±3.1; GEN125=11.6±2.1 and GEN250=12.3±2.3). The estradiol level was higher in the ECE group compared to the other groups (9.4±1.7 pg/mL; p<0.05), whereas serum levels of progesterone were similar in all groups. CONCLUSION: the administration of genistein at high doses had no trophic effect on the mammary glands of rats.
- ItemSomente MetadadadosEfeitos do 17 beta-estradiol e das isoflavonas da soja no útero de ratas diabéticas e ovariectomizadas(Universidade Federal de São Paulo (UNIFESP), 2020-12-16) Fonseca, Caio Cesar Navarrete Da [UNIFESP]; Simoes, Manuel De Jesus [UNIFESP]; Universidade Federal de São PauloIntroduction: Hormonal therapy (HT) with estrogen has benefits to climacteric symptoms in women, but it also brings a risk increase to breast and endometrium cancer. Soy isoflavones are phytoestrogens with weaker influence, whereas its administration could be solo or combined by those substances. A diabetic (Di) and ovariectomized (Ovx) animal model is proposed to a better understanding of its impacts in the uterus morphology. Objectives: Evaluate the isolated or combined effects of 17 beta-estradiol (E2) or soy isoflavones (Iso) in the uterus of ovariectomized and diabetic rats. Methods: 50 Wistar rats were separated into 10 groups: (I) sham-operated; (II) ovariectomized; (III) Ovx+E2 (10 µg/Kg/day); (IV) Ovx+Iso (200 mg/kg/day); (V) Ovx+E2+Iso; (VI) Sham+Di; (VII) Ovx+Di; (VIII) Ovx+E2+Di; (IX) Ovx+Iso+Di; and (X) Ovx+E2+Iso+Di. Uterine horns were collected after 50 days of treatment to histomorphometry analysis, and blood proceeded through biochemistry. Results: Uterine horns of Ovx rats had no trophic effect to the isoflavones replacement. The uterus and its lumen were increased in animals with E2 replacement, solo or combined with soy isoflavones. Triglycerides and HDL levels improved in animals treated with soy isoflavones. Diabetes had an impact in uterine morphology by discretely reducing it. Replacement with E2 stimulated the collagen fibers organization into uterine endometrium. Conclusions: Animals without diabetes were evaluated and soy isoflavones improved the lipid profile with no uterotrophic impact, and prevented the increased weight loss from diabetic animals. The combination of HT with 17 betaestradiol and soy isoflavones had similar results with the HT replacement with estradiol, and through those points it is not an alternative to the traditional therapy.
- ItemAcesso aberto (Open Access)Efeitos imediato e tardio das isoflavonas da soja e do estradiol na glândula mamária de ratas ovariectomizadas(Universidade Federal de São Paulo (UNIFESP), 2015-12-16) Santos, Miriam Aparecida dos [UNIFESP]; Simões, Manuel de Jesus [UNIFESP]; Carbonel, Adriana Aparecida Ferraz [UNIFESP]; http://lattes.cnpq.br/9174521191304809; http://lattes.cnpq.br/5987164343458678; http://lattes.cnpq.br/7415497496003016; Universidade Federal de São Paulo (UNIFESP)A importância do estrogênio na etiologia do câncer de mama é largamente reconhecida. Estudos indicam que mulheres que nunca receberam qualquer tipo de terapia hormonal (TH) na menopausa e que passaram a utilizá-la mais tardiamente, apresentam um aumento da resposta proliferativa em células da mama. Nesse contexto, as isoflavonas da soja têm sido investigadas como alternativa à TH. Objetivo: Nosso estudo objetiva investigar os efeitos do tratamento imediato e tardio das isoflavonas da soja ou do estradiol na glândula mamária de ratas ovariectomizadas. Metodologia: Utilizaram-se 30 ratas adultas ovariectomizadas (OVX) divididas em seis grupos (contendo 5 ratas em cada), sendo 3 grupos imediatos (tratados 3 dias após OVX) e 3 grupos tardios (tratados 30 dias após OVX). As ratas foram tratadas por 30 dias consecutivos, a saber: GI- Controle Imediato (Cont-Im) e GII- Controle Tardio (Cont-Tar) receberam 0,1 mL de solução veículo propilenoglicol por gavagem; GIII- Isoflavona Imediato (Iso-Im) e GIV- Isoflavona Tardio (Iso-Tar) receberam por gavagem 150 mg/Kg/dia de extrato de isoflavonas da soja; GVEstradiol Imediato (Est-Im) e GVI- Estradiol Tardio (Est-Tar) receberam 10?m/Kg/dia de 17?-estradiol por via subcutânea. Ao final dos tratamentos os animais foram eutanasiados e o 6o par de mamas inguinal foi retirado. Fragmentos do orgão foram mergulhados em formol a 10%, processados para estudo morfométrico; imunohistoquímico para o antígeno de proliferação celular Ki-67, antígeno de crescimento endotélio-vascular (VEGF-A) e ácido hialurônico (AH); e análise da birrefringência das fibras colágenas. Outros fragmentos foram mergulhados em acetona para determinação dos glicosaminoglicanos (GAGs). Resultados: Ambos os tratamentos com estradiol promoveram aumento das frações epitelial, ductal e lobular em comparação aos demais grupos estudados; e não observamos diferenças nestes parâmetros entre os grupos controle e isoflavonas. Na imunomarcação para o Ki-67 e VEGF-A os grupos tratados com estradiol apresentaram evidente aumento da imunopositividade a estes marcadores tanto no epitélio quanto no estroma mamário, em comparação aos controles e tratados com isoflavonas; que por sua vez apresentaram-se semelhantes entre si. Observamos também um aumento da imunoexpressão do AH nos ductos e estroma mamário de todas as ratas tratadas com estradiol em relação aos demais grupos, notando-se ainda uma semelhança entre os controles e isoflavonas, exceto no tratamento tardio com isoflavonas em que houve uma diminuição do AH em comparação ao controle. No estudo da matriz extracelular mamária observamos que ambos os tratamentos com estradiol promoveram aumento da concentração dos GAGs heparam sulfato, dermatam sulfato e ácido hialurônico em comparação aos demais grupos; não havendo diferenças nas concentrações destes GAGs entre os controles e isoflavonas, exceto no grupo isoflavonas tardio em que houve um aumento do heparam sulfato em relação ao controle. Além disso, notamos predominância de fibras colágenas com birrefringência avermelhada nos grupos tratados com estradiol, em relação aos grupos controles e isoflavonas, que apresentaram semelhantemente predominância de fibras colágenas esverdeadas. Conclusões: O estradiol administrado tanto imediatamente quanto tardiamente promoveu evidente proliferação do tecido mamário, enquanto as isoflavonas da soja não apresentaram este efeito.
- ItemSomente MetadadadosEffects of early and late treatment with soy isoflavones in the mammary gland of ovariectomized rats(Cuba Editora, 2016) Santos, Miriam Aparecida [UNIFESP]; Florencio-Silva, Rinaldo [UNIFESP]; Teixeira, Cristiane de Paula [UNIFESP]; Sasso, Gisela Rodrigues da Silva [UNIFESP]; Marinho, Darci Souza [UNIFESP]; Simões, Ricardo Santos; Simões, Manuel de Jesus [UNIFESP]; Carbonel, Adriana Aparecida Ferraz [UNIFESP]Introduction Soy isoflavones have been shown to be an alternative to hormone therapy at menopause, without causing side-effects such as breast cancer. However, the effects of early and late treatment with isoflavones on the mammary gland remain controversial.Objective To investigate the effects of early and late treatment with soy isoflavones on the mammary gland of ovariectomized rats.Methods Thirty 3-month-old rats were ovariectomized and divided equally into groups: Control, treated with vehicle solution
- ItemAcesso aberto (Open Access)Effects of isoflavones on the skin of postmenopausal women: a pilot study(Faculdade de Medicina / USP, 2009-06-01) Accorsi-Neto, Alfeu [UNIFESP]; Haidar, Mauro Abi [UNIFESP]; Simões, Ricardo dos Santos [UNIFESP]; Simões, Manuel de Jesus [UNIFESP]; Soares-Junior, José [UNIFESP]; Baracat, Edmund Chada [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade de São Paulo (USP)OBJECTIVE: The aim of this study was to evaluate the effects of isoflavones on the skin of postmenopausal women. DESIGN: A prospective study was performed with 30 postmenopausal women before and immediately after the end of treatment with 100 mg/day of an isoflavones-rich, concentrated soy extract for six months. A skin punch was performed in the gluteal region for sample collection before and immediately after the treatment program. Morphometric determination of epidermal thickness, the papillary index (wrinkling), and the amount of dermal elastic and collagen fibers was assessed. In addition, the number of blood vessels in the sample was also evaluated. The paired Student's t-test was used for statistical analysis (P < 0.05). RESULTS: Isoflavone treatment resulted in a 9.46% increase in the thickness of the epidermis in 23 patients. In addition, the papillary index was reduced in 21 women. The papillary index was inversely proportional to skin wrinkling, i.e., there were a large number of papillae after treatment. The amount of collagen in the dermis was increased in 25 women (86.2%). In 22 women (75.8%) we observed that the number of elastic fibers increased. The number of dermal blood vessels was significantly increased in 21 women. CONCLUSION: Our data show that the use of a concentrated, isoflavone-rich soy extract during six consecutive months caused significant increases in epithelial thickness, the number of elastic and collagen fibers, as well as the blood vessels.
- ItemSomente MetadadadosEffects of soy isoflavones on the concentration of hyaluronic acid in the vagina of type 1 diabetic rats(Taylor & Francis Ltd, 2017) Carbonel, A. A. F. [UNIFESP]; Azevedo Lima, P. D.; Lim, J. J.; Teixeira Borges, F. [UNIFESP]; Rodrigues da Silva Sasso, G. [UNIFESP]; Portugal Fuchs, L. F.; Simoes, R. S.; Chada Baracat, E.; Soares, J. M., Jr.; Simoes, M. J. [UNIFESP]Objective: To assess the effects of isoflavones and 17-estradiol on the vaginal epithelium extracellular matrix and hyaluronic acid (HA) in the diabetic rat model.Methods: Sixty adult, virgin, female rats underwent ovariectomy, then randomization into six groups of ten animals each: GI, sham ovariectomized control animals
- ItemSomente MetadadadosEffects of soy isoflavones on the uterus and urethra of ovariectomized rats(Springer, 2010-01-01) Santos, Elaine Travaglia [UNIFESP]; Dutra Sampaio, Maria Dione [UNIFESP]; Cecon, Paulo Roberto; Simoes, Manuel de Jesus [UNIFESP]; Ferreira Sartori, Marair Gracio [UNIFESP]; Batista Castello Girao, Manoel Joao [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade Federal de Viçosa (UFV)To evaluate the effect of soy isoflavone extract (SIE) on the uterus and urethra of castrated female rats.Ovariectomized adult virgin Wistar rats (n = 45) received, for 30 days: placebo (GI); SIE from day 5 of castration (GII); or day 28 of castration (GIII). A standardized SIE was administered by gavage at 125 mu g genistein/g body weight/day, with a soy-free diet. Average numbers of nuclei (NU), blood vessels (BV) and collagen fibers (CF) in uterus and mid-urethra sections were compared using Dunnett and Tukey tests (95% CI).Uterus: GII and GIII differed from GI in all respects; GII vs. GIII, no differences. Urethra: GIII vs. GI: no differences; GII vs. GI, differences in NU and CF; GII vs. GIII, differences in NU and CF.Early oral administration of SIE to ovariectomized rats reversed uterine/urethral effects of castration.
- ItemSomente MetadadadosThe effects of topical isoflavones on postmenopausal skin: Double-blind and randomized clinical trial of efficacy(Elsevier B.V., 2009-10-01) Moraes, Andrea B. [UNIFESP]; Haidar, Mauro Abi [UNIFESP]; Soares Junior, Jose Maria [UNIFESP]; Simoes, Manuel J. [UNIFESP]; Baracat, Edmund C.; Patriarca, Marisa T. [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade de São Paulo (USP)Objective: the aim of this study was to evaluate the effects of estrogen and isoflavones on postmenopausal skin morphological parameters.Study design: A randomized, double-blind, estrogen-controlled trial was performed on postmenopausal women treated in the Gynecology Department of the Federal University of São Paulo. This study was designed to analyze the effects of topical administration of estradiol and isoflavones on facial skin for 24 weeks. the participants were divided into two groups: G1-17-betaestradiol 0.01% (n = 18) and G2-isoflavones 40% (genistein 4%, n = 18). Skin biopsies were performed on each patient before and after the treatment. the skin samples were processed for histological analysis, stained with haematoxylin and eosin, and examined using light microscopy.Results: After 24 weeks of treatment, the estradiol group had a significant increase in skin parameters analyzed compared to the isoflavone group and to the baseline measurements: epidermal thickness (a 75% increase in the estrogen group and 20% in the isoflavone group), number of dermal papillae (a rise of 125% with estrogen, no significant gain with isoflavones), fibroblasts (a 123% accretion with estradiol, no significant gain with isoflavones), and vessels (a 77% increase with estrogen and 36% with isoflavones).Conclusion: Our data suggest that estrogens may have a stronger effect on histomorphometrical parameters than isoflavones. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
- ItemSomente MetadadadosFermented soy product supplemented with isoflavones affects adipose tissue in a regional-specific manner and improves HDL-cholesterol in rats fed on a cholesterol-enriched diet(Springer, 2008-10-01) Manzoni, Marla Simone Jovenasso; Rossi, Elizeu Antonio; Carlos, Iracilda Zeppone; Vendramini, Regina Celia; Duarte, Ana Claudia Garcia de Oliveira; Tenorio, Neuli Maria; Bernardes, Danielle; Dâmaso, Ana Raimunda [UNIFESP]; Univ Estadual Paulista; Universidade Federal de São Paulo (UNIFESP)It has been proposed that isoflavones and probiotics possess specific biological activities that enable them to affect lipid metabolism. the purpose of this study was to evaluate the effects of a soy product fermented with Enterococcus faecium and Lactobacillus jugurti and supplemented with isoflavones on the plasma lipid and glucose profiles, and on the retroperitoneal (RET) and epididymal (EPI) adipose tissue adipocyte areas in juvenile rats. Male Wistar rats were subjected to 6-week experimental diets: (1) cholesterol-enriched diet (rat chow) plus fermented soy product supplemented with isoflavones, (2) cholesterol-enriched diet plus unfermented placebo, (3) cholesterol-enriched diet plus placebo supplemented with isoflavones, (4) standard diet (rat chow), or (5) cholesterol-enriched diet. Soy products affected adipose tissue in a regional-specific manner and may be responsible for the observed increase in RET adipocyte area (mu(2)): (1) 12757.00 +/- 286.25; (2) 13269.00 +/- 326.87 or (3) 13050.00 +/- 226.85 versus (4) 8714.92 +/- 262.41 or (5) 8892.70 +/- 131.79 or decrease in EPI adipocyte area (mu(2)): (1) 7759.00 +/- 108.89 and (2) 7481.90 +/- 111.21 compared with the control group (4) 8346.60 +/- 158.89. the effect on epididymal adipose tissue was probably due to isoflavones. Probiotics significantly raised the plasma level of HDL cholesterol. Fermented soy product supplemented with isoflavones did not promote changes in the glucose and triglyceride plasma levels. This product may offer a new approach for improving or preventing lipid metabolism abnormalities by decreasing visceral adipocyte area, adjusting cholesterol-mediated loss of RET adipose tissue (lipoatrophy), and increasing the HDL cholesterol plasma level.
- ItemSomente MetadadadosIntake of isoflavone-supplemented soy yogurt fermented with Enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats(Springer, 2008-12-01) Rossi, Elizeu Antonio; Cavallini, Daniela Cardoso Umbelino; Carlos, Iracilda Zepone; Vendramini, Regina Celia; Dâmaso, Ana Raimunda [UNIFESP]; Valdez, Graciela Font de; Univ Estadual Paulista; São Paulo State Univ; Universidade Federal de São Paulo (UNIFESP); CERELAThe aim of this study was to obtain an isoflavone-supplemented soy yogurt, fermented with Enterococcus faecium CRL 183 and Lactobacillus helveticus ssp jugurti, with suitable sensory properties and to assess the effects of the final product on blood lipids in hypercholesterolemic rats. Four isoflavone supplementation procedures were tested, in which the isoflavone was added at these stages: (1) before heat-treatment; (2) after heating and before fermentation; (3) after fermentation and (4) in the okara (by-product of soy milk) flour stirred into the fermented product when consumed. the products were subjected to a test of sensory acceptability. To assess their potential hypocholesterolemic properties in vivo, four groups of rats were used: control (C), hypercholesterolemic (H), hypercholesterolemic plus fermented product (HF) and hypercholesterolemic plus isoflavone-supplemented fermented product (HFI). Hypercholesterolemia was induced in rats of groups H, HF and HFI by feeding them on a commercial rat chow to which cholesterol and cholic acid had been added. Total, HDL and non-HDL cholesterol and triglycerides were measured in the blood of the rats. No significant sensorial differences were detected among the samples of soy yogurt supplemented with isoflavones at various processing stages. Rats fed a fermented soy product enriched with isoflavones (HFI group) had significantly (P < 0.05) less serum total cholesterol (15.5%) compared with rats fed a hypercholesterolemic diet (H group). Non-HDL cholesterol was less (P < 0.05) in rats fed a fermented soy product enriched or not with isoflavones (27.4 and 23.2%) compared to H group. the HDL-C and triglyceride concentrations did not differ significantly among the groups. It was possible to obtain an isoflavone-supplemented soy yogurt with satisfactory sensory characteristics. the resulting supplemented soy yogurt was capable of producing a lipid-lowering effect in hypercholesterolemic rats, relative to the animals that did not consume this product.
- ItemSomente MetadadadosThe soybean concentrated extract proliferates the vagina of adult rats(Lippincott Williams & Wilkins, 2011-01-01) Ferraz Carbonel, Adriana Aparecida [UNIFESP]; Pinheiro Baracat, Maria Candida [UNIFESP]; Simoes, Ricardo Santos; Simoes, Manuel Jesus [UNIFESP]; Baracat, Edmund Chada; Soares, Jose Maria [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Universidade de São Paulo (USP)Objective: the aim of this study was to evaluate changes induced on the vagina of ovariectomized rats after treatment with soybean concentrated extract or conjugated equine estrogens and the association of both drugs.Methods: We conducted an experimental study with 50 ovariectomized rats that were randomly divided into five equal groups of 10 animals: GI received vehicle, GII received soybean concentrated extract 46 mg/kg per day, GIII received soybean concentrated extract 120 mg/kg per day, GIV received conjugated equine estrogens 50 mu g/kg per day, and GV received conjugated equine estrogens 50 mu g/kg and soybean concentrated extract 46 mg/kg per day. the substances were administered by gavage during 21 consecutive days. After that, the animals were killed under anesthesia and the vagina was removed for histological and immunohistochemical analysis. Data were initially submitted to analysis of variance. Whenever a significant difference was detected, the study was complemented with the Tukey-Kramer test for multiple comparisons.Results: GII did not show any differences on the vaginal epithelium or collagen compared with GI. GIII presented an increase in vaginal epithelium and collagen amount. GIV had the highest amount of collagen and the signals of vaginal proliferation. GV did not show any additional effect compared with GIV.Conclusions: Our data suggest that a high dose of isoflavone-rich soy extract may have positive effects on the vaginal structures of ovariectomized rats, but this action is less than that of estrogen treatment on vaginal thickness. in addition, soy extract may not block the estrogen effect on vaginal tissue.